Issue 2, 2013

Dinaphthonaphthyridines – a class of novel molecules with potent antioxidant and anticancer activity

Abstract

A series of novel dinaphtho[1,2-b:1′,2′-h][1,6]naphthyridine derivatives bearing aliphatic, aromatic and heteroaromatic substituents at the C7 position were designed and synthesized conveniently from 4-chloro-2-methylbenzo[h]quinoline. All compounds were screened for in vitro antioxidant activities against DPPH˙, ABTS˙+, superoxide and hydroxyl radicals. Among the compounds screened, 13, 15, 16, 19 and 20 showed excellent antioxidant activity against OH˙. In addition, the cytotoxicity of the dinaphthonaphthyridine derivatives was evaluated by MTT assay and compared with Adriamycin. From screening, we identified that compounds 6, 16 and 20 showed IC50s ranging from 1.20 to 5.61 μM for growth inhibition of HeLa, HCT116 and AGS cancer cell lines. The results documented that varying of the chemical entity at C7 can fine-tune the enhancement of cell growth inhibition strategy.

Graphical abstract: Dinaphthonaphthyridines – a class of novel molecules with potent antioxidant and anticancer activity

Supplementary files

Article information

Article type
Concise Article
Submitted
09 Sep 2012
Accepted
28 Oct 2012
First published
31 Oct 2012

Med. Chem. Commun., 2013,4, 340-346

Dinaphthonaphthyridines – a class of novel molecules with potent antioxidant and anticancer activity

K. Prabha and K. J. R. Prasad, Med. Chem. Commun., 2013, 4, 340 DOI: 10.1039/C2MD20270K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements